Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Derma Sciences, a provider of advanced wound care products, has launched two new formulations of its key product line, Medihoney wound and burn dressings.
Subscribe to our email newsletter
Derma’s Medihoney products consist of 100% active leptospermum honey packaged in a tube, and a patented colloidal sheet referred to as Honeycolloid.
The company said that these two new formulations will greatly enhance the brand’s utilization in variety of wounds, including lightly draining wounds, wounds that are difficult to dress due to their anatomical location, and wounds that are sensitive to pain at dressing changes.
Ed Quilty, CEO of Derma Sciences, said: “The addition of these new formulations, especially the patented Honeycolloid dressing, adds to the brand and further distances us from any other potential competitors.”